financetom
Business
financetom
/
Business
/
T2 Biosystems Shares Fall After Company Receives Nasdaq Non-Compliance Notice
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
T2 Biosystems Shares Fall After Company Receives Nasdaq Non-Compliance Notice
Nov 8, 2024 11:50 PM

12:24 PM EST, 11/08/2024 (MT Newswires) -- T2 Biosystems ( TTOO ) shares were down by more than 9% in recent Friday trading after the company said it received a Nasdaq non-compliance notice.

The notification stated that the market value of the company's listed securities no longer meets the $35 million minimum required for continued listing on the Nasdaq Capital Market, the company said.

T2 Biosystems ( TTOO ) said it was not granted any grace period but plans to request for a new hearing before the Nasdaq Hearings Panel, which will stay further action pending the panel's decision and the expiration of any extension that may be granted as a result of the hearing.

Price: 0.63, Change: -0.08, Percent Change: -11.75

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Venture Global Insider Sold Shares Worth $13,716,011, According to a Recent SEC Filing
Venture Global Insider Sold Shares Worth $13,716,011, According to a Recent SEC Filing
Sep 16, 2025
03:16 AM EDT, 09/16/2025 (MT Newswires) -- Thomas Earl, Chief Commercial Officer, on September 11, 2025, sold 1,000,000 shares in Venture Global ( VG ) for $13,716,011. SEC Filing: https://www.sec.gov/Archives/edgar/data/2007855/000095010325011674/xslF345X05/dp234375_4-earl.xml ...
Revolution Medicines Insider Sold Shares Worth $5,557,754, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $5,557,754, According to a Recent SEC Filing
Sep 16, 2025
03:16 AM EDT, 09/16/2025 (MT Newswires) -- Stephen Michael Kelsey, President, Research and Development, on September 11, 2025, sold 125,000 shares in Revolution Medicines ( RVMD ) for $5,557,754. Following the Form 4 filing with the SEC, Kelsey has control over a total of 289,414 common shares of the company, with 289,414 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071725000339/xslF345X05/form4.xml ...
BRIEF-Strathcona Resources Says Disappointed By Meg Board's Cenovus Deal Commitment
BRIEF-Strathcona Resources Says Disappointed By Meg Board's Cenovus Deal Commitment
Sep 16, 2025
Sept 16 (Reuters) - Strathcona Resources Ltd ( STHRF ): * STRATHCONA RESOURCES LTD. ( STHRF ) RESPONDS TO MEG BOARD RECOMMENDATION * STRATHCONA RESOURCES LTD ( STHRF ) - DISAPPOINTED BY MEG BOARD'S CENOVUS DEAL COMMITMENT * STRATHCONA RESOURCES LTD ( STHRF ) - TO VOTE 14.2% INTEREST AGAINST MEG DEAL * : STRATHCONA RESOURCES LTD ( STHRF )...
Sempra Insider Sold Shares Worth $2,430,567, According to a Recent SEC Filing
Sempra Insider Sold Shares Worth $2,430,567, According to a Recent SEC Filing
Sep 16, 2025
03:18 AM EDT, 09/16/2025 (MT Newswires) -- Kevin C. Sagara, Director, on September 15, 2025, sold 28,864 shares in Sempra ( SRE ) for $2,430,567. Following the Form 4 filing with the SEC, Sagara has control over a total of 17,880 common shares of the company, with 15,475 shares held directly and 2,405 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1032208/000181536025000007/xslF345X05/wk-form4_1757982828.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved